Skip to main content
Elizabeth Volkmann, MD, Rheumatology, Los Angeles, CA

Elizabeth Rita Volkmann MD

Scleroderma & Related


Physician

Join to View Full Profile
  • 200 UCLA Medical Plz# UnivLos Angeles, CA 90095

  • Phone+1 310-824-2448

  • Fax+1 310-825-2572

Are you Dr. Volkmann?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 1 invite waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Elizabeth Volkmann, MD is a rheumatologist in Los Angeles, California. She is currently licensed to practice medicine in California. She is affiliated with Ronald Reagan UCLA Medical Center.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2011 - 2013
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

Press Mentions

  • ILD in Rheumatic Diseases: Advice on Screening, Treating, and Monitoring
    ILD in Rheumatic Diseases: Advice on Screening, Treating, and MonitoringMarch 6th, 2025
  • Biomarker Changes in Systemic Sclerosis–Associated Lung Disease Predict Therapy Response
    Biomarker Changes in Systemic Sclerosis–Associated Lung Disease Predict Therapy ResponseJanuary 9th, 2025
  • Precision Medicine Benefits Patients with Systemic Sclerosis
    Precision Medicine Benefits Patients with Systemic SclerosisNovember 26th, 2024
  • Join now to see all

Grant Support

  • Identifying predictors of treatment response in systemic sclerosis-related interstitial lung diseaseUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025